ARM market-structure snapshot
Latest close on July 31, 2026: $239.69 (-0.8% on the latest daily bar). HMA21 / HMA55: $241.02 / $255.49. 200DMA: $189.88. Relative volume: 1.14x the 20-day average.
Latest close on July 31, 2026: $239.69 (-0.8% on the latest daily bar). HMA21 / HMA55: $241.02 / $255.49. 200DMA: $189.88. Relative volume: 1.14x the 20-day average.
ARM latest SEC/Yahoo fundamental and valuation snapshot
Latest comparable filing period: latest period. Valuation snapshot: trailing P/E 244.6x; forward P/E 78.1x; EV/EBITDA 237.5x; P/S 49.6x.
Latest comparable filing period: latest period.
Valuation snapshot: trailing P/E 244.6x; forward P/E 78.1x; EV/EBITDA 237.5x; P/S 49.6x.
forward P/E is materially below trailing P/E, implying higher expected earnings
Asia Technology: Qualcomm and Arm Earnings Takeaways—China’s Smartphone Market Has Bottomed but Not Rebounded, While Supply-Chain Divergence… (J.P. Morgan)
Based on earnings calls from Qualcomm (QCOM) and Arm, JPMorgan said China’s smartphone market may have bottomed, but underlying demand has yet to rebound. The supply chain is showing a structural divergence, with de-specification and a wave of price increases occurring simultaneously. Arm is optimistic about an AI CPU supercycle in 2027–28, while Qualcomm plans to enter the market for custom data-center chips.
Based on earnings calls from Qualcomm (QCOM) and Arm, JPMorgan said China’s smartphone market may have bottomed, but underlying demand has yet to rebound. The supply chain is showing a structural divergence, with de-specification and a wave of price increases occurring simultaneously. Arm is optimistic about an AI CPU supercycle in 2027–28, while Qualcomm plans to enter the market for custom data-center chips.
Arm’s AGI CPU story is compelling, but near-term trading calls for patience, with valuation already reflecting most expectations (Morgan Stanley). (Morgan Stanley)
Arm’s Q1 results beat expectations, but slower royalty growth in North America and a lack of long-term updates on its AGI CPU business overshadowed the positives. The company expects AGI CPU sales to exceed $1 billion in FY2027–FY2028, but supply coverage remains the primary constraint. Morgan Stanley believes the current valuation already reflects much of the 2030 CPU opportunity, leaving limited near-term upside.
Arm’s Q1 results beat expectations, but slower royalty growth in North America and a lack of long-term updates on its AGI CPU business overshadowed the positives. The company expects AGI CPU sales to exceed $1 billion in FY2027–FY2028, but supply coverage remains the primary constraint. Morgan Stanley believes the current valuation already reflects much of the 2030 CPU opportunity, leaving limited near-term upside.
